KKR (KKR) completed a $250 million investment in Henry Schein (HSIC) and holds a 12% stake in the health-care solution provider.
KKR's executive adviser, William Daniel, has joined Henry Schein's board in connection with the investment.
He joins Max Lin, a partner at KKR and leader of the firm's health care industry team in the Americas, who became a member of the board in early May, Henry Schein said Friday in a statement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.